ASTRO urges legislative action as reimbursement cuts continue in proposed FY25 MPFS

The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, in response to the proposed 2025 Medicare Physician Fee Schedule (MPFS) released yesterday by the Centers for Medicare and Medicaid Services (CMS): “The declines in reimbursement for radiation therapy services for people with cancer under the Medicare physician fee schedule are disappointing.

Continued Medicare Reimbursement Declines Could Threaten Access to Physicians

A new Harvey L. Neiman Health Policy Institute study found that physician reimbursement per Medicare patient decreased 2.3% between 2005 and 2021 when accounting for inflation, despite a concurrent increase of 45.5% in physician services to each patient. These reimbursement trends varied widely by physician specialty (-57.6% for cardiac surgery to +189.1% for pain management).

New proposed rule continues cuts to Medicare reimbursement; Legislative remedies needed to protect patients’ access to care

The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Chair of the ASTRO Board of Directors, in response to the proposed 2024 Medicare Physician Fee Schedule (MPFS) released today: “Another year brings another round of cuts to radiation therapy services for people with cancer under the proposed Medicare fee schedule.”

Final 2023 Medicare Physician Payment Rule Negatively Impacts Anesthesia Groups, Harms Patient Access to Surgical Care

The American Society of Anesthesiologists calls on Congress to block a nearly 4.5% Medicare payment cut to anesthesiologists and other physicians included in the Centers for Medicare & Medicaid Services (CMS) 2023 Medicare Physician Fee Schedule (PFS) final rule released yesterday.